Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Publication year range
1.
Bioorg Med Chem ; 25(1): 166-174, 2017 01 01.
Article in English | MEDLINE | ID: mdl-28340987

ABSTRACT

A series of curcumin derivatives as potent dual inhibitors of xanthine oxidase (XOD) and urate transporter 1 (URAT1) was discovered as anti-hyperuricemic agents. These compounds proved efficient effects on anti-hyperuricemic activity and uricosuric activity in vivo. More importantly, some of them exhibited proved efficient effects on inhibiting XOD activity and suppressing uptake of uric acid via URAT1 in vitro. Especially, the treatment of 4d was demonstrated to improve uric acid over-production and under-excretion in oxonate-induced hyperuricemic mice through regulating XOD activity and URAT1 expression. Docking study was performed to elucidate the potent XOD inhibition of 4d. Compound 4d may serve as a tool compound for further design of anti-hyperuricemic drugs targeting both XOD and URAT1.


Subject(s)
Curcumin/analogs & derivatives , Curcumin/therapeutic use , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/therapeutic use , Hyperuricemia/drug therapy , Organic Anion Transporters/antagonists & inhibitors , Organic Cation Transport Proteins/antagonists & inhibitors , Xanthine Oxidase/antagonists & inhibitors , Animals , Curcumin/pharmacology , Enzyme Inhibitors/pharmacology , HEK293 Cells , Humans , Hyperuricemia/metabolism , Male , Mice , Models, Molecular , Organic Anion Transporters/metabolism , Organic Cation Transport Proteins/metabolism , Uric Acid/metabolism , Xanthine Oxidase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL